bromodeoxyuridine has been researched along with Bladder Cancer in 54 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (22.22) | 18.7374 |
1990's | 31 (57.41) | 18.2507 |
2000's | 9 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (3.70) | 2.80 |
Authors | Studies |
---|---|
Antonova, O; Dolashka, P; Dolashki, A; Kaynarov, D; Velkova, L; Voelter, W | 1 |
Klinakis, A; Rampias, T | 1 |
Al-Sharef, W; Ayesh, S; De-Groot, N; Hochberg, A; Laster, M; Matouk, I; Ohana, P; Schneider, T | 1 |
Chang, HL; Chen, HW; Kao, YH; Lin, KH; Su, JH; Wu, YC; Yeh, YT; Yuan, SS | 1 |
Fukushima, S; Kaneko, M; Kinoshita, A; Kinoshita, H; Morimura, K; Nishikawa, T; Ogawa, M; Osugi, H; Salim, EI | 1 |
Asamoto, M; Hokaiwado, N; Ito, A; Shirai, T | 1 |
Balakrishnan, S; Eastmond, DA | 1 |
Arnold, LE; Cano, M; Cohen, SM; Dominick, MA; Moehlenkamp, JD; Sanderson, TP; Schilling, BE; Tannehill-Gregg, S; Van Vleet, T; Waites, CR; White, MR | 1 |
Harder, J; Kamradt, J; Lehmann, J; Paulsen, F; Retz, M; Stöckle, M; Suttmann, H; Unteregger, G; Wullich, B; Zwergel, U | 1 |
Tchao, R | 1 |
Hashimoto, Y; Kawamura, H | 1 |
Christensen, IJ; Kieler, J; Larsen, JK | 1 |
Beattie, GM; Cirulli, V; Hayek, A; Lopez, AD; Ricordi, C; Rubin, JS | 1 |
Baba, S; Deguchi, N; Miyakawa, A; Murai, M; Tachibana, M; Tazaki, H | 1 |
Miyakawa, A; Tachibana, M; Tazaki, H | 1 |
Carroll, PR; Chew, K; Cohen, MB; Kerschmann, R; Mayall, BH; Waldman, FM | 2 |
Carroll, P; Chew, K; Gudat, F; Kerschmann, R; Mihatsch, MJ; Moch, H; Moore, D; Sauter, G; Waldman, F | 1 |
Carroll, P; Chew, K; Gudat, F; Haley, J; Kerschmann, R; Mihatsch, MJ; Moch, H; Moore, D; Sauter, G; Waldman, F | 1 |
Baba, S; Deguchi, N; Hata, M; Jitsukawa, S; Tachibana, M; Tazaki, H | 2 |
Bair, R; Bernhart, P; Bigler, A; Limas, C; Reddy, P | 1 |
Coptcoat, MJ; Joyce, AD; Popert, RJ; Thomas, DJ; Walmsley, BH | 1 |
Baba, S; Miyakawa, A; Murai, M; Nakamura, K; Tachibana, M; Tazaki, H | 1 |
Brugal, G | 1 |
Chen, H; Endo, G; Fukushima, S; Hori, T; Wanibuchi, H; Yamamoto, S; Yoshida, K | 1 |
Au, JL; Weaver, JR | 1 |
Akaza, H; Hattori, K; Ota, T; Uchida, K | 1 |
Deguchi, T; Hirose, Y; Kawada, Y; Mori, H; Tanaka, T; Yang, M | 1 |
Au, JL; Badalament, RA; Gan, Y; Wientjes, MG | 1 |
Chen, TX; Fukushima, S; Kitano, M; Murai, T; Wanibuchi, H; Yamamoto, S | 1 |
Arnold, LL; Cano, M; Cohen, SM; Eldan, M; St John, M; van Gemert, M | 1 |
Asamoto, M; Kimoto, N; Nakanishi, M; Ogawa, K; Shirai, T; Takahashi, S | 1 |
Chen, TX; Fukushima, S; Hayashi, S; Morimura, K; Wanibuchi, H; Wei, M; Yamamoto, S | 1 |
Deguchi, T; Hara, A; Katayama, M; Mori, H; Sugie, S; Tanaka, T; Vinh, PQ; Yamada, Y | 1 |
Carroll, PR; Cohen, MB; Field, FG; Kerschmann, R; Mayall, BH; Waldman, FM | 1 |
Coptcoat, M; Rew, DA; Thomas, DJ; Wilson, GD | 1 |
Kurita, T; Matsuda, H; Nakanishi, A; Tsujihashi, H; Uejima, S | 1 |
Bush, C; Parkins, CS; Price, P; Steel, GG | 1 |
Fair, WR; Melamed, MR; Pizzolo, JG; Schervish, EW; Van Dekken, H | 1 |
Akiyama, T; Kurita, T; Matsuda, H; Tsujihashi, H; Uejima, S | 3 |
Fujisawa, M; Hashimoto, H; Kaneko, S; Sasaki, M; Tokunaka, S; Yachiku, S | 1 |
Harada, M; Hattori, K; Koiso, K; Nemoto, R; Shimazui, T; Uchida, K | 2 |
Hayashi, T; Hoshi, S; Kurosu, S; Mituno, S; Murakami, F; Nakazumi, H; Ohyama, C; Orikasa, S; Satoh, M; Yoshikawa, K | 1 |
Hofstadter, F; Jenkins, WE; Knuchel, R; Masters, JR | 1 |
Matsuyama, H; Sakatoku, J; Shimabukuro, T; Yamamoto, M; Yamamoto, N; Yoshihiro, S | 1 |
Langkilde, NC; Orntoft, TF; Wolf, H | 1 |
Harada, H; Mitsui, H; Sacho, T; Sakatoku, J; Shimabukuro, T; Yamamoto, M; Yamamoto, N | 1 |
Aoki, T; Fukushima, S; Inoue, T; Ito, N; Mera, Y; Tatematsu, M | 1 |
Shimabukuro, T | 1 |
Harada, M; Hattori, K; Koiso, K; Nemoto, R; Nishijima, Y; Saito, S; Shimazui, T; Uchida, K | 1 |
1 trial(s) available for bromodeoxyuridine and Bladder Cancer
Article | Year |
---|---|
Role of proliferative activity estimated by bromodeoxyuridine labeling index in determining predictive factors of recurrence in superficial intermediately malignant bladder tumors.
Topics: Actuarial Analysis; Adult; Aged; Aged, 80 and over; Bromodeoxyuridine; Carcinoma, Transitional Cell; Cell Division; DNA, Neoplasm; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ploidies; Predictive Value of Tests; Urinary Bladder Neoplasms | 1996 |
53 other study(ies) available for bromodeoxyuridine and Bladder Cancer
Article | Year |
---|---|
Selective Cytotoxicity and Changes in Protein Expression of T24 Bladder Carcinoma Permanent Cell Line after Treatment with Hemocyanins.
Topics: Bromodeoxyuridine; Carcinoma; Cell Line, Tumor; Doxorubicin; Hemocyanins; Humans; Protein Isoforms; Proteome; Proteomics; Urinary Bladder; Urinary Bladder Neoplasms | 2022 |
Using Sister Chromatid Exchange Assay to Detect Homologous Recombination Deficiency in Epigenetically Deregulated Urothelial Carcinoma Cells.
Topics: Bromodeoxyuridine; Carcinoma, Transitional Cell; Chromatids; Homologous Recombination; Humans; Sister Chromatid Exchange; Urinary Bladder Neoplasms | 2023 |
Possible physiological role of H19 RNA.
Topics: Bromodeoxyuridine; Cell Cycle Proteins; Cell Division; Cell Movement; Coloring Agents; Culture Media, Serum-Free; Cyclin-Dependent Kinase Inhibitor p27; DNA Primers; Gene Expression Profiling; Humans; Luciferases; Neoplasm Invasiveness; Neoplasm Metastasis; Oligonucleotide Array Sequence Analysis; Oxazines; Proliferating Cell Nuclear Antigen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Long Noncoding; RNA, Neoplasm; RNA, Untranslated; Transfection; Tumor Cells, Cultured; Tumor Suppressor Proteins; Urinary Bladder Neoplasms; Xanthenes | 2002 |
Annonacin, a mono-tetrahydrofuran acetogenin, arrests cancer cells at the G1 phase and causes cytotoxicity in a Bax- and caspase-3-related pathway.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; bcl-2-Associated X Protein; Blotting, Western; Bromodeoxyuridine; Carcinoma, Transitional Cell; Caspase 3; Caspase Inhibitors; Caspases; Cell Survival; Flow Cytometry; Fluorescent Antibody Technique; Furans; G1 Phase; Humans; Lactones; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2003 |
High susceptibility of p53 knockout mice to esophageal and urinary bladder carcinogenesis induced by N, N-dibutylnitrosamine.
Topics: Alleles; Animals; Body Weight; Bromodeoxyuridine; Carcinogens; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Esophageal Neoplasms; Genes, p53; Genetic Predisposition to Disease; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Mutation; Nitrosamines; Organ Size; Point Mutation; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Sequence Analysis, DNA; Time Factors; Urinary Bladder Neoplasms | 2003 |
Regulation of cell proliferation by induction of p21/WAF1 in rat bladder carcinoma cells using the Cre--loxP system.
Topics: Animals; Blotting, Western; Bromodeoxyuridine; Carcinoma; Cell Cycle; Cell Division; Cell Separation; Coloring Agents; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA Nucleotidyltransferases; Flow Cytometry; Genes, p53; Genetic Techniques; Genetic Vectors; Integrases; Models, Genetic; Mutation; Polymorphism, Single-Stranded Conformational; Rats; Recombinases; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Viral Proteins | 2003 |
Micronuclei and cell proliferation as early biological markers of ortho-phenylphenol-induced changes in the bladder of male F344 rats.
Topics: Agrochemicals; Animals; Biomarkers, Tumor; Biphenyl Compounds; Bromodeoxyuridine; Cell Proliferation; Dose-Response Relationship, Drug; Male; Micronuclei, Chromosome-Defective; Mutagenicity Tests; Rats; Rats, Inbred F344; Urinary Bladder; Urinary Bladder Neoplasms; Urothelium | 2006 |
Urothelial carcinogenesis in the urinary bladder of male rats treated with muraglitazar, a PPAR alpha/gamma agonist: Evidence for urolithiasis as the inciting event in the mode of action.
Topics: Animals; Antimetabolites; Apoptosis; Area Under Curve; Bromodeoxyuridine; Calcium; Carcinogens; Cell Proliferation; Citrates; Electrolytes; Glycine; Hydrogen-Ion Concentration; Immunohistochemistry; Male; Microscopy, Electron, Scanning; Organ Size; Oxalates; Oxazoles; Phosphates; PPAR alpha; PPAR gamma; Proteinuria; Rats; Rats, Sprague-Dawley; Spectrometry, X-Ray Emission; Urinary Bladder Neoplasms; Urolithiasis; Urothelium | 2006 |
Antimicrobial peptides of the Cecropin-family show potent antitumor activity against bladder cancer cells.
Topics: Anti-Infective Agents; Antimicrobial Cationic Peptides; Antineoplastic Agents; Bromodeoxyuridine; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Insect Proteins; Microscopy, Electron, Scanning; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2008 |
Keratinization and the effect of vitamin A in aggregates of a squamous carcinoma cell line NBT II.
Topics: Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Aggregation; Cell Differentiation; Cell Line; Cytarabine; DNA, Neoplasm; Keratins; Mitosis; Rats; Urinary Bladder Neoplasms; Vitamin A | 1980 |
Inhibitory effect of 5-halogenated deoxyuridines on in vitro keratinization of a transformed rat urinary bladder epithelial cell line.
Topics: Animals; Binding, Competitive; Bromodeoxyuridine; Cell Line; Cell Transformation, Neoplastic; DNA Replication; Epithelium; Floxuridine; Idoxuridine; Keratins; Rats; RNA, Neoplasm; Thymidine; Urinary Bladder Neoplasms; Vitamin A | 1981 |
Cell cycle perturbation by sodium butyrate in tumorigenic and non-tumorigenic human urothelial cell lines assessed by flow cytometric bromodeoxyuridine/DNA analysis.
Topics: Amnion; Aneuploidy; Anticarcinogenic Agents; Bromodeoxyuridine; Butyrates; Butyric Acid; Cell Cycle; Cell Division; Cell Transformation, Neoplastic; DNA; Epithelial Cells; Epithelium; Flow Cytometry; Humans; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1995 |
Growth factor/matrix-induced proliferation of human adult beta-cells.
Topics: Adult; Animals; Bromodeoxyuridine; Cell Adhesion; Cell Division; Culture Media, Conditioned; Culture Techniques; DNA; Hepatocyte Growth Factor; Humans; Islets of Langerhans; Rats; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1995 |
A new scoring system based on the histological behavior and proliferative activity of tumor cells for grading the malignant potential of bladder cancers.
Topics: Bromodeoxyuridine; Carcinoma, Transitional Cell; Cell Division; DNA, Neoplasm; Follow-Up Studies; Humans; Neoplasm Staging; Ploidies; Regression Analysis; Retrospective Studies; Risk Factors; Survival Rate; Urinary Bladder Neoplasms | 1994 |
Flow cytometric measurements of deoxyribonucleic acid ploidy and proliferative activity for evaluating malignant potential of human bladder cancers.
Topics: Aneuploidy; Bromodeoxyuridine; Carcinoma, Transitional Cell; Cell Transformation, Neoplastic; DNA; Flow Cytometry; Humans; Neoplasm Invasiveness; Prognosis; Survival Rate; Urinary Bladder Neoplasms | 1995 |
5-Bromodeoxyuridine incorporation and PCNA expression as measures of cell proliferation in transitional cell carcinoma of the urinary bladder.
Topics: Aged; Bromodeoxyuridine; Carcinoma, Transitional Cell; Cell Division; Female; Humans; Male; Neoplasm Staging; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Urinary Bladder Neoplasms | 1993 |
Heterogeneity of erbB-2 gene amplification in bladder cancer.
Topics: Bromodeoxyuridine; Gene Amplification; Gene Expression; Heterozygote; Humans; In Situ Hybridization, Fluorescence; Neoplasm Staging; Oncogene Proteins, Viral; Receptor, ErbB-2; Urinary Bladder Neoplasms | 1993 |
Comparison of five histopathologic methods to assess cellular proliferation in transitional cell carcinoma of the urinary bladder.
Topics: Bromodeoxyuridine; Carcinoma, Transitional Cell; Cell Division; Humans; Ki-67 Antigen; Mitosis; Neoplasm Proteins; Nuclear Proteins; Nucleolus Organizer Region; Proliferating Cell Nuclear Antigen; Urinary Bladder Neoplasms | 1993 |
Epidermal-growth-factor-receptor expression is associated with rapid tumor proliferation in bladder cancer.
Topics: Bromodeoxyuridine; Carcinoma, Papillary; Cell Division; Centromere; Chromosomes, Human, Pair 17; ErbB Receptors; Gene Amplification; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Neoplasm Recurrence, Local; Neoplasm Staging; Urinary Bladder Neoplasms | 1994 |
Prognostic significance of bromodeoxyuridine high labeled bladder cancer measured by flow cytometry: does flow cytometric determination predict the prognosis of patients with transitional cell carcinoma of the bladder.
Topics: Actuarial Analysis; Bromodeoxyuridine; Carcinoma, Transitional Cell; DNA, Neoplasm; Flow Cytometry; Follow-Up Studies; Humans; Ploidies; Prognosis; Proportional Hazards Models; Survival Analysis; Time Factors; Urinary Bladder; Urinary Bladder Neoplasms | 1993 |
Proliferative activity of urothelial neoplasms: comparison of BrdU incorporation, Ki67 expression, and nucleolar organiser regions.
Topics: Antigens, Neoplasm; Bromodeoxyuridine; Carcinoma, Transitional Cell; Cell Count; Cell Division; Humans; Ki-67 Antigen; Middle Aged; Mitotic Index; Neoplasm Proteins; Nuclear Proteins; Nucleolus Organizer Region; Prognosis; Urinary Bladder Neoplasms | 1993 |
Bromodeoxyuridine labelling of transitional cell carcinoma of the bladder--an index of recurrence?
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Bromodeoxyuridine; Carcinoma, Transitional Cell; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Male; Middle Aged; Mitotic Index; Neoplasm Recurrence, Local; Prognosis; Urinary Bladder Neoplasms | 1993 |
Quantitative microscopy and tumour cell proliferation.
Topics: Adenocarcinoma; Biomarkers, Tumor; Bromodeoxyuridine; Cell Cycle; Cell Transformation, Neoplastic; Cytophotometry; Humans; Ki-67 Antigen; Microscopy, Immunoelectron; Neoplasm Proteins; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1995 |
Promoting effects of dimethylarsinic acid on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in rats.
Topics: Animals; Bromodeoxyuridine; Butylhydroxybutylnitrosamine; Cacodylic Acid; Carcinogens; Cell Division; Cocarcinogenesis; Dose-Response Relationship, Drug; Epithelium; Male; Microscopy, Electron, Scanning; Rats; Rats, Inbred F344; Urinary Bladder; Urinary Bladder Neoplasms | 1996 |
Comparative scoring by visual and image analysis of cells in human solid tumors labeled for proliferation markers.
Topics: Bromodeoxyuridine; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Immunoenzyme Techniques; Proliferating Cell Nuclear Antigen; Reproducibility of Results; Staining and Labeling; Urinary Bladder Neoplasms | 1997 |
[The relationship between the estimated tumor growth speed and indices of bromodeoxyuridine (BrdU) incorporation and the proliferating cell nuclear antigen (PCNA) expression in superficial bladder cancer].
Topics: Adult; Aged; Aged, 80 and over; Bromodeoxyuridine; Cell Division; Female; Humans; Male; Middle Aged; Neoplasm Invasiveness; Proliferating Cell Nuclear Antigen; Retrospective Studies; Urinary Bladder Neoplasms | 1997 |
Chemopreventive effects of diosmin and hesperidin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary-bladder carcinogenesis in male ICR mice.
Topics: Administration, Oral; Animals; Bromodeoxyuridine; Butylhydroxybutylnitrosamine; Carcinogens; Diosmin; DNA, Neoplasm; Drug Combinations; Hesperidin; Male; Mice; Mice, Inbred ICR; Nucleolus Organizer Region; Precancerous Conditions; Silver Staining; Urinary Bladder Diseases; Urinary Bladder Neoplasms | 1997 |
Pharmacodynamics of doxorubicin in human bladder tumors.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bromodeoxyuridine; Doxorubicin; Female; Humans; Male; Middle Aged; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms | 1996 |
Promotion by sodium L-ascorbate in rat two-stage urinary bladder carcinogenesis is dependent on the interval of administration.
Topics: Animals; Ascorbic Acid; Bromodeoxyuridine; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma; Drug Administration Schedule; Hyperplasia; Male; Papilloma; Rats; Rats, Inbred F344; Time Factors; Urinary Bladder; Urinary Bladder Neoplasms | 1999 |
Effects of dietary dimethylarsinic acid on the urine and urothelium of rats.
Topics: Animals; Body Weight; Bromodeoxyuridine; Cacodylic Acid; Diet; Drinking Behavior; Feeding Behavior; Female; Hydrogen-Ion Concentration; Male; Microscopy, Electron, Scanning; Rats; Rats, Inbred F344; Urinary Bladder Neoplasms; Urine; Urothelium | 1999 |
Aberrant expression of p27(Kip1) is associated with malignant transformation of the rat urinary bladder epithelium.
Topics: Animals; Bromodeoxyuridine; Butylhydroxybutylnitrosamine; Cell Cycle Proteins; Cyclin D1; Cyclin E; Cyclin-Dependent Kinase Inhibitor p27; Male; Microtubule-Associated Proteins; Papilloma; Rats; Rats, Inbred F344; Tumor Suppressor Proteins; Uracil; Urinary Bladder Calculi; Urinary Bladder Neoplasms | 2000 |
Concentration dependent promoting effects of sodium L-ascorbate with the same total dose in a rat two-stage urinary bladder carcinogenesis.
Topics: Animals; Ascorbic Acid; Bromodeoxyuridine; Butylhydroxybutylnitrosamine; Carcinogens; Dose-Response Relationship, Drug; Male; Rats; Rats, Inbred F344; Urinary Bladder Neoplasms | 1999 |
Chemopreventive effects of a flavonoid antioxidant silymarin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.
Topics: Administration, Oral; Animals; Anticarcinogenic Agents; Antioxidants; Bromodeoxyuridine; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma, Transitional Cell; Cell Cycle; Cyclin D1; Male; Mice; Mice, Inbred ICR; Papilloma; Precancerous Conditions; Silymarin; Urinary Bladder Neoplasms | 2002 |
Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer.
Topics: Aged; Aged, 80 and over; Bromodeoxyuridine; Carcinoma, Transitional Cell; Cell Division; Centromere; Chromosome Aberrations; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 7; Chromosomes, Human, Pair 9; Female; Humans; Interphase; Male; Middle Aged; Mitotic Index; Neoplasm Staging; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Urinary Bladder Neoplasms | 1991 |
Measurement of in vivo urological tumour cell kinetics using multiparameter flow cytometry. Preliminary study.
Topics: Aneuploidy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; DNA, Neoplasm; Flow Cytometry; Humans; Kidney Neoplasms; Kinetics; Male; Mitosis; Penile Neoplasms; Prostatic Neoplasms; S Phase; Urinary Bladder Neoplasms | 1991 |
Cell proliferation of human bladder tumors determined by BrdUrd and Ki-67 immunostaining.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Surface; Bromodeoxyuridine; Cell Division; Female; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Mitotic Index; S Phase; Urinary Bladder Neoplasms | 1991 |
Cell proliferation in human tumour xenografts: measurement using antibody labelling against bromodeoxyuridine and Ki-67.
Topics: Animals; Antibodies, Monoclonal; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Female; Humans; Immunoenzyme Techniques; Ki-67 Antigen; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Nuclear Proteins; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms | 1991 |
Quantification of cell kinetic characteristics using flow cytometric measurements of deoxyribonucleic acid and bromodeoxyuridine for bladder cancer.
Topics: Aneuploidy; Bromodeoxyuridine; Carcinoma, Transitional Cell; Cell Cycle; DNA, Neoplasm; Flow Cytometry; Humans; Immunoenzyme Techniques; Urinary Bladder; Urinary Bladder Neoplasms | 1991 |
Simultaneous detection of fluorescent in situ hybridization and in vivo incorporated BrdU in a human bladder tumour.
Topics: Bromodeoxyuridine; Cell Division; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 9; DNA Probes; DNA, Neoplasm; Fluorescent Antibody Technique; Humans; Monosomy; Nucleic Acid Hybridization; Urinary Bladder Neoplasms | 1991 |
The kinetics of cellular proliferation in rat urinary bladder treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Topics: Animals; Bromodeoxyuridine; Butylhydroxybutylnitrosamine; Cell Division; Cystectomy; Female; Rats; Rats, Inbred Strains; Urinary Bladder; Urinary Bladder Neoplasms | 1990 |
[The changes of population and distribution of S-phase cells in precancerous lesions of rat bladder revealed by the method of bromodeoxyuridine labeling].
Topics: Animals; Bromodeoxyuridine; Cell Transformation, Neoplastic; Histocytochemistry; Precancerous Conditions; Rats; Rats, Inbred Strains; S Phase; Urinary Bladder Neoplasms | 1990 |
Estimation of growth fraction in situ in human bladder cancer with bromodeoxyuridine labelling.
Topics: Aged; Aged, 80 and over; Bromodeoxyuridine; Carcinoma, Transitional Cell; Cell Division; Humans; Male; Middle Aged; Neoplasm Invasiveness; Urinary Bladder Neoplasms | 1990 |
[S-phase cells of human bladder tumors by in vivo bromodeoxyuridine labeling].
Topics: Aged; Aged, 80 and over; Bromodeoxyuridine; Carcinoma, Transitional Cell; Female; Humans; Immunohistochemistry; Infusions, Intravenous; Interphase; Male; Middle Aged; Urinary Bladder Neoplasms | 1990 |
Sensitivities of monolayers and spheroids of the human bladder cancer cell line MGH-U1 to the drugs used for intravesical chemotherapy.
Topics: Administration, Topical; Bromodeoxyuridine; Carcinoma, Transitional Cell; Cell Survival; DNA, Neoplasm; Doxorubicin; Drug Screening Assays, Antitumor; Humans; Thiotepa; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1989 |
[Study of flow cytometric bromodeoxyuridine (BrdU)/DNA analysis using human solid tumors].
Topics: Animals; Bromodeoxyuridine; DNA, Neoplasm; Evaluation Studies as Topic; Female; Flow Cytometry; Fluorescent Antibody Technique; Humans; Mice; Neoplasm Transplantation; Pepsin A; Urinary Bladder Neoplasms | 1989 |
DNA replication in experimental rat bladder tumours: immunohistochemical detection of bromodeoxyuridine labelled nuclei.
Topics: Animals; Bromodeoxyuridine; Cell Nucleus; DNA Replication; Female; Immunoenzyme Techniques; Rats; Rats, Inbred Strains; Urinary Bladder Neoplasms | 1989 |
Cell proliferation of human bladder tumors.
Topics: Adult; Aged; Aged, 80 and over; Bromodeoxyuridine; Cell Division; Epithelium; Female; Humans; Interphase; Male; Middle Aged; Neoplasm Recurrence, Local; Reference Values; Urinary Bladder; Urinary Bladder Neoplasms | 1989 |
[Cell kinetic study of urogenital tumors utilizing in vitro BrdU-labelling method and anti-BrdU monoclonal antibody].
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Bromodeoxyuridine; Carcinoma, Transitional Cell; Cell Cycle; Female; Humans; Kidney Neoplasms; Kidney Pelvis; Lymphoma; Male; Middle Aged; Ureteral Neoplasms; Urethral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms | 1989 |
Patterns of epithelial proliferation revealed by continuous administration of bromodeoxyuridine during urinary bladder carcinogenesis in rats.
Topics: Animals; Bromodeoxyuridine; Butylhydroxybutylnitrosamine; Carcinoma, Transitional Cell; Cell Division; Epithelial Cells; Epithelium; Hyperplasia; Male; Nitrosamines; Rats; Rats, Inbred F344; Urinary Bladder; Urinary Bladder Neoplasms | 1987 |
[Application of simultaneous flow cytometric bromodeoxyuridine (BrdU)/DNA analysis. 2. Basic study to apply as a chemosensitivity test].
Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Cell Cycle; Cisplatin; DNA; Doxorubicin; Drug Screening Assays, Antitumor; Flow Cytometry; Mice; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Vincristine | 1988 |
[Cell cycle kinetics of human bladder tumor in situ measured by bromodeoxyuridine (BrdU)].
Topics: Adult; Aged; Antibodies, Monoclonal; Bromodeoxyuridine; Carcinoma, Transitional Cell; Cell Cycle; Female; Humans; Male; Middle Aged; Urinary Bladder Neoplasms | 1988 |
[Immunohistochemical demonstration of S-phase cells in bladder tumors by anti-bromodeoxyuridine monoclonal antibody. Using in vitro labeling method].
Topics: Aged; Antibodies, Monoclonal; Bromodeoxyuridine; DNA, Neoplasm; Female; Humans; Immunohistochemistry; Interphase; Male; Middle Aged; Urinary Bladder Neoplasms | 1988 |
S phase fraction of human bladder tumor measured in situ with bromodeoxyuridine labeling.
Topics: Adult; Aged; Antibodies, Monoclonal; Bromodeoxyuridine; Carcinoma, Transitional Cell; Female; Humans; Immunoenzyme Techniques; Interphase; Male; Middle Aged; Urinary Bladder Neoplasms | 1988 |